Alissa is a patent specialist in the Patents group. She focuses her practice on worldwide intellectual property protection and strategic counseling for life sciences, biotechnology and biomedical engineering clients. She previously worked as a patent scientist at Washington University’s Office of Technology Management. Alissa received her Ph.D. from Washington University in St. Louis in Biological and Biomedical Sciences with a concentration in Molecular Microbiology and Microbial Pathogenesis. She graduated summa cum laude from Brigham Young University, in Provo, UT, where she majored in Physiology and Developmental Biology and minored in Microbiology.
I have experience drafting and prosecuting patents across a wide variety of biotechnologies, including microbiology (microbiome, probiotics, antibiotics), pharmaceuticals (small and large molecule therapeutics), immunology (immuno-cell therapy, targeted cancer therapies, vaccines), regenerative medicine, biochemistry, molecular biology, diagnostic tests and medical devices.
As researchers continue to dissect the complexities of the microbiome, the fight to secure patent protection related to probiotics, sequencing and even the virome will only continue to intensify. For more insights about this developing patent landscape, please check out our group’s patent alerts in Gut Check: Microbiome Patent Update.